A Regulatory View on Adaptive/Flexible Clinical Trial Design
From MaRDI portal
Publication:5122841
DOI10.1002/BIMJ.200610229zbMATH Open1442.62419OpenAlexW2161966436WikidataQ33999536 ScholiaQ33999536MaRDI QIDQ5122841FDOQ5122841
Authors:
Publication date: 24 September 2020
Published in: Biometrical Journal (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1002/bimj.200610229
Recommendations
- Adaptive and flexible clinical trials
- A consultant's perspective on the regulatory hurdles to adaptive trials
- Some recent developments in the design of adaptive clinical trials
- Adaptive design methods in clinical trials
- Adaptation in clinical development plans and adaptive clinical trial designs
- On the efficiency of adaptive designs for flexible interim decisions in clinical trials
- Challenges in implementing adaptive designs: comments on the viewpoints expressed by regulatory statisticians
- Confirmatory clinical trials with an adaptive design
- Some optimal adaptive designs in clinical trials
non-inferioritystatistical informationstatistical efficiencysuperiorityadaptive information designdropping a treatment armregulatory evaluation
Cited In (7)
- Ethics, data-dependent designs, and the strategy of clinical trials: time to start learning-as-we-go?
- Challenges and regulatory experiences with non‐inferiority trial design without placebo arm
- Multicentre trials: a US regulatory perspective
- Plan to be Flexible: A Commentary on Adaptive Designs
- A consultant's perspective on the regulatory hurdles to adaptive trials
- Practical and statistical considerations in designing an early phase II osteoarthritis clinical trial: a case study
- Multicentre trials: a US regulatory perspective
This page was built for publication: A Regulatory View on Adaptive/Flexible Clinical Trial Design
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5122841)
